Literature DB >> 27658720

Improvement in verbal memory performance in depressed in-patients after treatment with electroconvulsive therapy.

S V Biedermann1,2, J M Bumb3, T Demirakca1, G Ende1, A Sartorius1,3.   

Abstract

OBJECTIVE: Electroconvulsive therapy (ECT) is a highly effective and well-tolerated therapy for severe and treatment-resistant depression. Cognitive side-effects are still feared by some patients and clinicians. Importantly, cognitive impairments are among the most disabling symptoms of depression itself.
METHODS: Patients suffering from a severe episode of depression were treated with either ECT or treatment as usual (TAU) in an in-patient setting. Matched healthy participants served as controls (HC). Verbal memory was tested with the California Verbal Learning Test (CVLT) before the specific treatment started (ECT = 15, TAU = 16, HC = 31) and 2 months after the last ECT session or 2 months after discharge respectively.
RESULTS: Before the specific treatment started, depressed patients performed substantially worse compared with HC in total, short- and long-delay recall in the CVLT, while the ECT group showed the worst performance. More severely depressed patients showed worse performances in these measures. Intriguingly, verbal memory showed a significant improvement in ECT-treated patients, but not in the other groups. No differences between the groups were found at follow-up.
CONCLUSION: Contrary to the widely feared assumption that ECT has long-term impact on memory functions, we found evidence that ECT is superior to TAU in improving verbal memory in depressed patients.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  California Verbal Learning Test; cognitive dysfunction; declarative memory; electroconvulsive therapy; major depression

Mesh:

Year:  2016        PMID: 27658720     DOI: 10.1111/acps.12652

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

1.  Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder.

Authors:  Haihua Tian; Guangxue Li; Guoan Xu; Jimeng Liu; Xiaohan Wan; Jiao Zhang; Shuguang Xie; Jia Cheng; Shugui Gao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-05-02       Impact factor: 5.270

2.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

3.  Depression and episodic memory across the adult lifespan: A meta-analytic review.

Authors:  Taylor A James; Samuel Weiss-Cowie; Zachary Hopton; Paul Verhaeghen; Vonetta M Dotson; Audrey Duarte
Journal:  Psychol Bull       Date:  2021-11       Impact factor: 23.027

Review 4.  [Treatment against the patient's will exemplified by electroconvulsive therapy : Clinical, legal and ethical aspects].

Authors:  D Zilles; M Koller; I Methfessel; S Trost; A Simon
Journal:  Nervenarzt       Date:  2018-03       Impact factor: 1.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.